Prévalence de la dyslipidémie dans la population rurale de Guéoul (Sénégal)

Thiombiano, L.; Mbaye, A.; Sarr, Simon Antoine; Ngaïdé, Aliou Alassane; Kane, Abdoul; Diao, Maboury; Kane, Adama; Bâ, Serigne Abdou

doi:10.1016/j.ancard.2015.09.045

Cited by 9 publications

(11 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The prevalence of hypercholesterolemia among our study patients was higher than that observed among the general population [ 41 ]. Other studies in Sub-Saharan Africa found higher hypercholesterolemia rates among HIV patients when compared to ours [ 18 , 47 – 50 ]. Higher proportions of hypercholesterolemia were also observed to be associated with a variety of factors including the patient being ART experienced (vs. ART naive) [ 51 , 52 ] or having prolonged exposure to the drugs stavudine and efavirenz [ 53 , 54 ].…”

Section: Discussioncontrasting

confidence: 51%

High rates of hypertension, diabetes, elevated low-density lipoprotein cholesterol, and cardiovascular disease risk factors in HIV-infected patients in Malawi

Rücker

Tayea

Bitilinyu-Bangoh

et al. 2018

Aids

View full text Add to dashboard Cite

Objectives:Data on cardiovascular disease risks among HIV-infected patients taking antiretroviral therapy (ART) over long periods of time are lacking in Sub-Saharan Africa.Methods:A cross-sectional study was conducted in Chiradzulu, Malawi from December 2015 to June 2016. HIV-infected persons on ART for more than 10 years (patients) and HIV-negative individuals (controls) from selected clinics participated. Following informed consent, a standardized questionnaire, clinical and laboratory examinations were performed. The prevalence of cardiovascular disease risk factors was calculated and stratified by age group.Results:Overall, 379 HIV-infected patients and 356 controls participated. Median time on ART among patients was 11.6 years (interquartile range 10.6–12.4).Within the 30–44, 45–59, and at least 60-year age groups, respectively, the prevalence of hypertension was 10.8, 20.4, and 44.7% among patients and 6.1, 25.8, and 42.9% among controls. Hypertension was previously undiagnosed in 60.3% patients and 37.0% controls with elevated blood pressure. The prevalence of diabetes within the respective age groups was 5.0, 6.4, and 13.2% among patients, and 3.4, 4.2, and 1.7% among controls. HIV-infected patients were more likely to have an glycated hemoglobin at least 6.0% (adjusted odds ratio 1.9; 95% confidence interval 1.1–3.2, P = 0.02). Prevalence of low-density lipoprotein cholesterol more than 130 mg/dl within the respective age groups was 8.0, 15.4, and 23.7% among patients and 1.8, 12.5, and 11.8% among controls.Conclusion: Noncommunicable diseases were a significant burden in Malawi, with high prevalence of hypercholesterolemia in all survey participants and an especially acute diabetes burden among older HIV infected. Hypertension screening and treatment services are needed among identified high-risk groups to cover unmet needs.

show abstract

Section: Discussioncontrasting

confidence: 51%

High rates of hypertension, diabetes, elevated low-density lipoprotein cholesterol, and cardiovascular disease risk factors in HIV-infected patients in Malawi

Rücker

Tayea

Bitilinyu-Bangoh

et al. 2018

Aids

View full text Add to dashboard Cite

show abstract

“…Ces chiffres sont superposables à ceux retrouvés par Tiahou et ses collaborateurs [ 12 ] qui ont effectué une étude similaire au CHU de Cocody en Côte d'Ivoire. Ils corroborent aussi les prévalences retrouvées dans des enquêtes épidémiologiques portant sur les facteurs de risque cardio-vasculaires réalisées à St Louis [ 7 ] et à Guéoul [ 8 ]. Nos résultats dépassent largement ceux retrouvés en Algerie (14,3%) [ 13 ] et en Mauritanie (>14,8%) [ 14 ] et se rapprochent des prévalences observées dans les pays industrialisés qui dépassent 30% [ 1 – 3 ].…”

Section: Discussionunclassified

“…Au Sénégal, malgré la fréquence des maladies cardio-vasculaires, les données sur la prévalence des facteurs de risque sont rares. Seules quelques enquêtes épidémiologiques ont été réalisées dans la ville de St Louis [ 6 , 7 ] et en zone rurale (Guéoul) [ 8 ]. La recherche de ces facteurs de risque et leur prise en charge adéquate pourrait contribuer à prévenir les maladies cardio-vasculaires.…”

Section: Introductionunclassified

Prévalence des dyslipidémies au laboratoire de biochimie du CHU Aristide le Dantec de Dakar, Sénégal

Cissé¹,

Agne²,

Diatta³

et al. 2016

Pan Afr Med J

View full text Add to dashboard Cite

IntroductionL'objectif de cette étude était d'évaluer la prévalence des dyslipidémies chez les patients reçus au laboratoire de Biochimie de l'Hôpital Aristide Le Dantec pour le dosage d'un paramètre lipidique au cours de l'année 2013.MéthodesIl s'agit d'une étude rétrospective portant sur 1356 patients âgés de 10 à 94 ans reçus au laboratoire de Biochimie du CHU Le Dantec de janvier à décembre 2013. Etaient inclus dans l'étude, tous les patients ayant au moins un paramètre du bilan lipidique dont les résultats étaient enregistrés dans le registre du laboratoire. Le cholestérol total, le cholestérol HDL, le cholestérol LDL ainsi que les triglycérides ont été dosés grâce à des méthodes enzymatiques sur un automate de Biochimie de type Cobas Integra 400 (Roche Diagnostics).RésultatsLa prévalence des dyslipidémies dans notre population d'étude est de 39,30%. Les prévalences de l'hypercholestérolémie, l'hypoHDLémie, l'hyperLDLémie, l'hypertriglycéridémie et l'hyperlipidémie mixte étaient respectivement : 30,89% ; 7,30% ; 31,19% ; 0,51% ; 7,22%. Les sujets de 40 à 59 ans semblaient être plus exposés et on note une prédominance féminine en ce qui concerne l'hypercholestérolémie (54,17% vs 45,82%), l'hypoHDLémie (54,54% vs45, 45%), et l'hyperlipidémie mixte (51,08% vs 48,97%). Enfin les dyslipidémies étaient fortement corrélées à l'HTA et l'obésité.ConclusionLa forte prévalence des dyslipidémies retrouvée dans notre étude démontre l'intérêt d'étudier la prévalence des facteurs de risque cardio-vasculaires en particulier les dyslipidémies dans la population sénégalaise.

show abstract

“…Dyslipidemia, a primary or secondary pathological change in serum lipids, is one of the major risk factors for cardiovascular disease [1][2]. It is defined by a more or less variable of low rate of high-density lipoprotein (HDL) cholesterol and high rate of low-density lipoprotein (LDL) cholesterol and/or triglycerides [3].…”

Section: Introductionmentioning

confidence: 99%

“…With the epidemiological transition of cardiovascular diseases in sub-Saharan Africa, we are witnessing the outbreak of these diseases and especially ischemic heart diseases [7]. At the same time, dyslipidemia is more and more frequent among the populations of the developing countries due to changes in dietary (meals rich in seeds and low in fruits and vegetables) and behavioral (sedentary lifestyle, lack of physical exercise) habits [1]. It's in this context of emerging cardiovascular diseases that we are carrying out this study in order to assess the extent of dyslipidemia in patients with cardiovascular pathologies.…”

Section: Introductionmentioning

confidence: 99%

Lipid Profile and Prevalence of Dyslipidemia in Hypertensive Patients at the Kara University Hospital Center (Togo)

Tchérou¹,

Yayehd²,

Abena³

et al. 2020

CCR

View full text Add to dashboard Cite

Prévalence de la dyslipidémie dans la population rurale de Guéoul (Sénégal)

Cited by 9 publications

References 3 publications

High rates of hypertension, diabetes, elevated low-density lipoprotein cholesterol, and cardiovascular disease risk factors in HIV-infected patients in Malawi

High rates of hypertension, diabetes, elevated low-density lipoprotein cholesterol, and cardiovascular disease risk factors in HIV-infected patients in Malawi

Prévalence des dyslipidémies au laboratoire de biochimie du CHU Aristide le Dantec de Dakar, Sénégal

Lipid Profile and Prevalence of Dyslipidemia in Hypertensive Patients at the Kara University Hospital Center (Togo)

Contact Info

Product

Resources

About